1. In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53. Issue 5 (5th April 2019) Authors: Van den Bossche, Jolien; Deben, Christophe; De Pauw, Ines; Lambrechts, Hilde; Hermans, Christophe; Deschoolmeester, Vanessa; Jacobs, Julie; Specenier, Pol; Pauwels, Patrick; Vermorken, Jan Baptist; Peeters, Marc; Lardon, Filip; Wouters, An Journal: Molecular oncology Issue: Volume 13:Issue 5(2019) Page Start: 1196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗